Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record.

COX‐2 selective NSAID decreases bone ingrowth in vivo

Open access
Goodman, Stuart, Ma, Ting, Trindade, Michael, Ikenoue, Takashi, Matsuura, Ippe, Wong, Neal, Fox, Nora, Genovese, Mark, Regula, Don, Smith, R. Lane · 2002 · Journal of Orthopaedic Research

Abstract

Whether non‐steroidal anti‐inflammatory drug (NSAID)—induced suppression of bone ingrowth is due to cyclooxygenase‐1 (COX‐1) inhibition, cyclooxygenase‐2 (COX‐2) inhibition, or through a yet unidentified pathway is unknown. In this study, the effects of a non‐specific COX‐1 and COX‐2 inhibitor, versus a specific COX‐2 inhibitor on bone ingrowth and tissue differentiation are examined in vivo. Harvest chambers were implanted unilaterally in the tibiae of eight mature, New Zealand white rabbits. After a 6‐week period for osseointegration of the chamber, the following oral treatments were given for 4 weeks each, followed by a harvest in each case: drinking water with no NSAID (control 1), Naproxen sodium–a COX‐1 and COX‐2 non‐specific inhibitor at a dose of 110 mg/kg/day in the drinking water, drinking water with no NSAID (control 2), and Rofecoxib—a COX‐2 inhibitor at a dose of 12.5 mg/day inserted directly into the rabbit's mouth. Harvested specimens were snap frozen, cut into serial 6 μm sections and stained with hematoxylin and eosin for general morphological characterization, and alkaline phosphatase (osteoblast marker). Sections were also processed for immunoperoxidase staining using monoclonal antibodies to identify cells expressing the vitronectin receptor (osteoclast‐like cells). With drinking water alone, the percentage of bone ingrowth averaged 24.8 ± 2.9% and 29.9 ± 4.5% respectively. Naproxen sodium in the drinking water and oral Rofecoxib decreased bone ingrowth significantly (15.9 ± 3.3%, p = 0.031 and 18.5 ± 2.4%, p = 0.035 compared to drinking water respectively). Both Naproxen sodium (p = 0.026) and Rofecoxib (p = 0.02) decreased the number of CD51 positive osteoclast‐like cells per section compared with drinking water alone. Rofecoxib decreased the area of osteoblasts per section area (p = 0.014) compared to controls, although the value for Naproxen sodium did not reach statistical significance. The results of the present study suggest that bone formation is suppressed by oral administration of an NSAID which contains a COX‐2 inhibitor. COX‐2 inhibitors currently taken for arthritis and other conditions may potentially delay fracture healing and bone ingrowth. © 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0736-0266(02)00079-7

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 174

Metadata

Authors
Goodman, S., Ma, T., Trindade, M., Ikenoue, T., Matsuura, I., Wong, N., Fox, N., Genovese, M., Regula, D., & Smith, R. L.
Venue
Journal of Orthopaedic Research
Publisher
Wiley
Published
2002-11
Volume
20
Issue
6
Pages
1164-1169
ISSN
  • 0736-0266 (ISSN-L)
  • 1554-527X
OpenAlex
W2014363460
Cited by
174
References
0
FWCI
6.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COX‐2 selective NSAID decreases bone ingrowth in vivo. https://app.cochat.ai/papers/10.1016/s0736-0266(02)00079-7
The paper
Goodman, S., Ma, T., Trindade, M., Ikenoue, T., Matsuura, I., Wong, N., Fox, N., Genovese, M., Regula, D., & Smith, R. L. (2002). COX‐2 selective NSAID decreases bone ingrowth in vivo. Journal of Orthopaedic Research. https://doi.org/10.1016/s0736-0266(02)00079-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.